返回 Agenda
Session Chair(s)
Joachim Vollmar, MSC
Executive Consultant
International Clinical Development Consultants LLC (ICDC), United States
Speaker(s)
Assessment of Subgroups in Significant and Non-Significant Clinical Trials
Armin Koch, DRSC
Hannover Medical School, Germany
Head, Institute of Biometry
Confirmatory Subgroup Analyses: Case studies
Frank Bretz, PHD
Novartis , Switzerland
Distinguished Quantitative Research Scientist
Subgroup Selection: Adaptive Clinical trials
Vladimir Dragalin, PHD
Janssen R&D, at Johnson & Johnson, United States
Vice President, Scientific Fellow